A carregar...
Why tyrosine kinase inhibitor resistance is common in advanced gastrointestinal stromal tumors
Background: Most patients with advanced gastrointestinal stromal tumors (GIST) develop drug resistance to tyrosine kinase inhibitors (TKIs) within two years of starting therapy, whereas most chronic myeloid leukemia (CML) patients in chronic phase still exhibit disease control after a decade on ther...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
F1000Research
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3892920/ https://ncbi.nlm.nih.gov/pubmed/24555070 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/f1000research.2-152.v1 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|